Neuroprotective Autophagic Flux Induced by Hyperbaric Oxygen Preconditioning is Mediated by Cystatin C
- 559 Downloads
We have previously reported that Cystatin C (CysC) is a pivotal mediator in the neuroprotection induced by hyperbaric oxygen (HBO) preconditioning; however, the underlying mechanism and how CysC changes after stroke are not clear. In the present study, we demonstrated that CysC expression was elevated as early as 3 h after reperfusion, and this was further enhanced by HBO preconditioning. Concurrently, LC3-II and Beclin-1, two positive-markers for autophagy induction, exhibited increases similar to CysC, while knockdown of CysC blocked these elevations. As a marker of autophagy inhibition, p62 was downregulated by HBO preconditioning and this was blocked by CysC knockdown. Besides, the beneficial effects of preserving lysosomal membrane integrity and enhancing autolysosome formation induced by HBO preconditioning were abolished in CysC−/− rats. Furthermore, we demonstrated that exogenous CysC reduced the neurological deficits and infarct volume after brain ischemic injury, while 3-methyladenine partially reversed this neuroprotection. In the present study, we showed that CysC is biochemically and morphologically essential for promoting autophagic flux, and highlighted the translational potential of HBO preconditioning and CysC for stroke treatment.
KeywordsStroke Ischemia/reperfusion HBO preconditioning Cystatin C Autophagy Autophagic flux
Stroke is the second leading cause of mortality worldwide, causing 6.5 million deaths in 2013 . It is also the major cause of lifelong disability, thereby a major concern in health care and neuroscience [2, 3]. Despite numerous efforts exploring drugs for ischemic stroke, no new neuroprotectant has been applied in clinical practice except for tissue plasminogen activator which was successfully introduced in 1995 [2, 3, 4].
Hyperbaric oxygen (HBO) preconditioning induces tolerance against ischemic neuronal injury, and is effective both in vitro and in vivo . Owing to fewer clinical side-effects, HBO preconditioning has been under intense investigation . Although neuroprotection is well defined, the mechanisms underlying HBO preconditioning remain elusive. Recently, we reported that Cystatin C (CysC), a lysosomal cysteine protease inhibitor, is a key mediator of the neuroprotection induced by HBO preconditioning . However, how CysC changes after stroke and the mechanism underlying the neuroprotection mediated by CysC are unclear. In the current study, we investigated the changes of CysC after brain ischemia and explored the CysC-autophagy-neuroprotection linkage.
Materials and Methods
All experiments were reviewed and approved by the Ethics Committee for Animal Experiments of the Fourth Military Medical University (Xi’an, China). Adult male Sprague-Dawley rats (8 weeks–10 weeks old, 250 g–300 g) were purchased from the University.
Generation of CysC-knockout Rats
A genome editing technique based on transcriptional activator-like effector nucleases (TALEN) was used to produce CysC-knockout rats by targeting exon 1 of CysC . To confirm the efficiency of CysC deletion, sequencing analysis was performed to detect base-pair deletions and western blot to assess the protein levels of CysC.
Rats were randomly assigned to the control or HBO group. The rats in the HBO group were exposed to hyperbaric oxygen (2.5 atmospheres absolute and 100% O2, 1 h/day) for five consecutive days. The control rats were placed in the hyperbaric chamber with air at normal pressure.
Transient Focal Cerebral Ischemia and Cerebral Blood Flow Estimation
Transient focal cerebral ischemia was achieved using a right middle cerebral artery occlusion (MCAO) model. Briefly, rats were anesthetized intraperitoneally (i.p.) with pentobarbital sodium (50 mg/kg). The right common carotid and external carotid arteries were exposed through a ventral midline neck incision. A monofilament (Beijing Sunbio Biotech Co., Ltd, Beijing, China) with a rounded tip was inserted into the common carotid immediately below the bifurcation. Then, it was advanced into the internal carotid ~ 18 mm–20 mm distal to the bifurcation until a mild resistance was felt, indicating occlusion of the middle cerebral artery. After 2 h, the middle cerebral artery was re-perfused by retracting the intraluminal monofilament. The regional cerebral blood flow of all rats subjected to ischemia/reperfusion (I/R) injury was monitored using a PF 5000 Laser Doppler Perfusion Monitoring Unit (PeriFlux 5000, Perimed AB, Stockholm, Sweden). The intervention was considered successful only if the regional cerebral blood flow sharply decreased to ≤ 30% of the baseline level after MCAO, and increased to ≥ 70% of the baseline level within 10 min of reperfusion.
Intracerebroventricular Injection of CysC siRNA, Exogenous CysC and 3-Methyladenine
Twenty microliters of 20 μmol/L CysC siRNA or scrambled siRNA was infused into the right lateral ventricle 3 days before MCAO as reported previously . The rats were anesthetized with pentobarbital sodium and placed in a stereotaxic apparatus. A burr hole was drilled into the skull 1.5 mm lateral and 1.0 mm posterior to bregma over the right hemisphere. A stainless-steel 26-gauge cannula (C315G, Plastic One, Roanoke, VA) was slowly introduced through the burr hole into the right lateral ventricle (3.8 mm beneath the dural surface). Reagents were infused into the ventricle at 0.5 μL/min. The CysC siRNA transfection complex was prepared according to the manufacturer’s instructions. The target sequence 5′-CCCAGACAAATTTGACTAACT -3′ was used.
3-Methyladenine (3-MA) (30 μg in 10 μL artificial cerebrospinal fluid, Sigma-Aldrich) was administered by intracerebroventricular injection 30 min before ischemia , while exogenous CysC (40 μg/kg) dissolved in artificial cerebrospinal fluid was delivered into the right lateral ventricle 30 min after reperfusion .
Three hours post-reperfusion, the rats were deeply anesthetized before sequential perfusion with ice-cold saline and 4% paraformaldehyde in phosphate-buffered saline (PBS). The brains were removed and dehydrated in a sucrose gradient (20%–30%) in PBS at 4 °C. Coronal sections (10 μm thick) at bregma ± 2 mm were cut on a cryostat and stored at −20 °C until further use. The slices were blocked with 3% normal goat serum in 0.5% Triton X-100 for 30 min at room temperature. Subsequently, the slices were incubated with primary antibodies at 4 °C overnight, followed by incubation with secondary antibodies for 2 h at room temperature. The following antibodies were used: rabbit polyclonal anti-cathepsin B and mouse monoclonal anti-NeuN (both 1:1000, Abcam). DAPI (4’,6-diamidino-2-phenylindole; 1:1000; Sigma-Aldrich) was used to stain nuclei. The following secondary antibodies were used: green-fluorescent Alexa Fluor 488-conjugated donkey anti-mouse and red-fluorescent Alexa Fluor 594-conjugated donkey anti-rabbit (both 1:1000; Abcam). Fluorescent signals in the right penumbra region of cortex (2 mm lateral from the midline) were detected using confocal laser scanning microscopy (FV1000, Olympus, Tokyo, Japan).
The designated region (penumbra: tissue less severely hypo-perfused than the ischemic core, and where neurons are functionally impaired but not yet irreversibly damaged) in the right cortex (between sections + 2 mm and − 3 mm of bregma) was separated after cold saline perfusion as described previously , and whole-cell protein was extracted using a total protein extraction kit (Merck Millipore). An equivalent of 40 µg protein from each sample was resolved on 12% SDS-PAGE. The following primary antibodies were used: anti-CysC (1:1000, Abcam), anti-LC3-I (1:1000, Sigma-Aldrich), anti-LC3-II (1:1000, Sigma-Aldrich), anti-Beclin 1 (1:1000, Cell Signaling), and anti-p62 (1:1000, Abcam). Goat anti-rabbit antibody was used as the secondary antibody (1:5000, Cell Signaling).
Rats were anesthetized with 1% sodium pentobarbital (50 mg/kg i.p.) and perfused transcardially with 150 mL ice-cold 0.9% saline, followed by 500 mL cold mixture of 4% paraformaldehyde, 0.05% glutaraldehyde, and 15% (v/v) saturated picric acid in 0.1 mol/L phosphate buffer (pH 7.4) for 2 h. The brains were excised and fixed in the same fixative at 4 °C for 3 h. Serial coronal sections (50 μm) were cut on a vibratome (VT 1000S, Leica) and incubated overnight with the primary antibody rabbit anti-cathepsin B (1:100 in PBS containing 1% BSA). Subsequently, the sections were washed in PBS and incubated overnight with anti-rabbit IgG conjugated to 1.4 nm gold particles (Nanoprobes) at 1:100. After rinsing, the sections were post-fixed in 2% glutaraldehyde in PBS for 45 min. Silver enhancement was performed in the dark with an HQ Silver Kit (Nanoprobes) for visualization of cathepsin B immunoreactive signals. Before and after the silver enhancement step, the sections were rinsed several times with deionized water and incubated in ABC solution (Sigma-Aldrich) for 4 h, followed by visualization using the glucose oxidase-3,3′-diaminobenzidine method. The immunolabeled sections were fixed in 0.5% osmium tetroxide in 0.1 mol/L phosphate buffer for 1 h, dehydrated in an ethanol gradient and propylene oxide, and embedded in Epon 812 (SPI-CHEM, West Chester, PA). After polymerization, the sections were examined by light microscopy. Three sections containing cathepsin B immunoreactivity were selected from each rat, trimmed under a stereomicroscope, and mounted on new resin stubs. Ultrathin sections were cut on an ultra-microtome (EM UC6, Leica), mounted on mesh grids (6–8 sections/grid) followed by counterstaining with uranyl acetate and lead citrate, and observed in a JEM-1230 electron microscope (JEOL Ltd, Tokyo, Japan). Electron-micrographs were captured by a Gatan digital camera and analyzed with its software (832 SC1000, Gatan, Warrendale, PA).
SPSS 19.0 was used for statistical analysis. All data are presented as mean ± SEM and were analyzed using one-way ANOVA followed by the Dunnett or Bonferroni post hoc test. Differences were considered significant if the P value was < 0.05.
HBO Preconditioning Enhances CysC Up-regulation After I/R Injury
Autophagic Flux Enhanced by HBO Preconditioning is CysC-Dependent
CysC Preserved Lysosomal Membrane Integrity and Prompted Autolysosome Formation
3-Methyladenine Attenuated the Neuroprotective Effect of Exogenous Cystatin C against Focal Cerebral Ischemic Injury
Our results, for the first time, showed that the expression of CysC was elevated in the penumbra after ischemic injury and HBO preconditioning further enhanced this elevation. Since CysC started to increase as early as 3 h after I/R and our previous research had demonstrated that the elevation of LC3-II and Beclin-1 also occurred as early as 3 h , we selected 3 h as the time point. LC3-II and Beclin-1 exhibited an increase similar to CysC. Conversely, HBO preconditioning significantly decreased the p62 protein level. Moreover, knocking down CysC decreased the upregulation of LC3-II and Beclin-1, while reversing the downregulation of p62. Furthermore, HBO preconditioning preserved the integrity of the lysosome membrane and enhanced the formation of autolysosomes in WT rats. These advantages of HBO preconditioning disappeared in CysC−/− rats. Above all, our results provided both biochemical and morphological evidence that CysC induced neuroprotection against ischemic injury through enhancing autophagic flux.
CysC is a potent endogenous inhibitor of lysosomal cysteine proteinases. Notably, it is abundant in the central nervous system, emphasizing its crucial role in the brain . A recent study demonstrated that CysC prevents oxidative injury . Exogenous CysC is neuroprotective by reducing the infarct volume in ischemic stroke in rats ; this phenomenon is in agreement with our recent result . However, besides the maintenance of lysosomal integrity , little is known about the mechanism of elevated CysC in mediating the neuroprotection induced by HBO preconditioning.
As a lysosomal cysteine protease inhibitor, CysC is crucial for lysosomal function and is closely associated with autophagy [10, 12, 14], which is a vital self-repair process for neuronal survival after ischemic injury . Furthermore, autophagy involves the processes of induction, delivery of autophagy substrates to lysosomes, and degradation of substrates inside lysosomes, defined as “autophagic flux” . Previously, we demonstrated that HBO preconditioning enhances the induction of autophagy, such as up-regulating LC3-II/LC3-I and Beclin-1 . Recently, we demonstrated that CysC is critical in maintaining lysosomal integrity . However, it had neither been determined whether HBO preconditioning affects autophagic flux after stroke nor the function of CysC in mediating autophagy induced by HBO preconditioning. Here, we evaluated autophagic flux by studying the levels of LC3-II, Beclin-1, and p62, which are essential markers for the induction and degradation of autophagy, respectively. We demonstrated that HBO preconditioning not only promoted the induction, but also enhanced the degradation in a CysC-dependent manner. It should be noted that our results demonstrated that CysC was essential for the upregulation of Beclin-1, which is the mammalian orthologue of yeast Atg6 and plays a central role in autophagy . As a component of the vps34 complex, Beclin-1 interacts with several cofactors (Atg14L, UVRAG, Bif-1, Rubicon, Ambra1, IP3R, PINK, and survivin), thereby regulating many major steps in autophagic pathways, from autophagosome formation to autophagosome/endosome maturation . Besides, as a novel Bcl-2-homology (BH)-3-only protein, Beclin-1 interacts with members of the anti-apoptotic Bcl-2 family . Therefore, CysC may play multiple roles in enhancing autophagic flux and regulating apoptosis. It is important that future studies assess the precise roles of CysC and Beclin-1 in autophagy and apoptosis.
Tizon et al. reported that CysC modulates autophagy induction through mTOR under multiple neuronal challenges in vitro , which is in line with our current findings in vivo. On the other hand, the process of autophagy requires functional lysosomes to degrade the autophagosomal cargo . In the current study, CysC−/− rats were used to show that CysC was pivotal in preserving lysosomal membrane integrity against brain ischemia. Furthermore, our immuno-electron microscopic results in WT and CysC−/− rats indicated that CysC was essential in promoting the formation of autolysosomes, which is the key feature of a completed autophagic process. However, although our results indicated that CysC affects the protein levels of LC3-II, Beclin-1, and p62, the underlying mechanism remains to be clarified. Besides, the roles of CysC in other autophagy-regulating molecules, such as mTOR and ULK1/2, need further exploration.
To confirm the role of autophagy in the neuroprotection that results from CysC, an intracerebroventricular injection of 3-MA, which suppresses the formation of autophagosomes by inhibiting class III phosphatidylinositol 3-kinase , was administered 30 min before ischemia. The results showed that exogenous CysC induced robust neuroprotection against ischemic injury, which is in accord with our previous results . Besides, 3-MA attenuated the neuroprotective effect of exogenous CysC. This result is in agreement with a previously published study showing that 3-MA inhibits the protective effect of CysC by blocking the activation of autophagy in vitro . However, as 3-MA only compromised, but did not block the neuroprotection induced by CysC, it is likely that CysC has multiple neuroprotective actions other than enhancing autophagy.
Nevertheless, the current study has some limitations. First, we did not explore the effect of exogenous CysC in promoting autophagy during cerebral ischemia. Second, the mechanism underlying the CysC-enhanced autophagic flux, including autophagy induction, degradation, and lysosome preservation is not clear. In our latest study we found that transcription factor EB, a master regulator of lysosomal biogenesis and autophagy, was dramatically lower in CysC−/− rats (data not shown). This phenomenon may to some extent explain why CysC affected the entire process of autophagic flux, but this need further exploration.
In summary, using gene manipulation technology, we demonstrated that CysC is a determinant for the neuroprotective effect of HBO preconditioning through promoting autophagic flux in the brain after ischemia. Our findings further clarify the mechanism underlying the neuroprotection of HBO preconditioning and CysC; this may facilitate their clinical application.
This work was supported by the National Natural Science Foundation of China (81420108013, 81730032), a Young Scholar Research Grant from the Chinese Anesthesiologist Association (21700005), and a Youth Project (81300989).
Conflict of interest
All authors claim that there are no conflicts of interest.
- 9.Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 1998, 29: 1037–1046; discussion 1047.Google Scholar
- 11.Martens S, Nakamura S, Yoshimori T. Phospholipids in autophagosome formation and fusion. J Mol Biol 2016. pii: S0022-2836(16)30455-7.Google Scholar
- 16.Gallagher LE, Williamson LE, Chan EY. Advances in autophagy regulatory mechanisms. Cells 2016, 5. pii: E24.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.